68 related articles for article (PubMed ID: 28565870)
1. C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I.
Kim K; Kim MJ; Kim KH; Ahn SA; Kim JH; Cho JY; Yeo SG
Exp Ther Med; 2017 May; 13(5):2493-2500. PubMed ID: 28565870
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
3. A novel homozygous variant in
Alstrup M; Vogel I; Sandager P; Blechingberg J; Becher N; Østergaard E
JIMD Rep; 2021 May; 59(1):20-25. PubMed ID: 33977026
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial p32/C1qbp Is a Critical Regulator of Dendritic Cell Metabolism and Maturation.
Gotoh K; Morisaki T; Setoyama D; Sasaki K; Yagi M; Igami K; Mizuguchi S; Uchiumi T; Fukui Y; Kang D
Cell Rep; 2018 Nov; 25(7):1800-1815.e4. PubMed ID: 30428349
[TBL] [Abstract][Full Text] [Related]
5. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
6. C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response.
Wang Q; Chai D; Sobhani N; Sun N; Neeli P; Zheng J; Tian H
Front Physiol; 2022; 13():1012112. PubMed ID: 36467687
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial C1qbp promotes differentiation of effector CD8
Zhai X; Liu K; Fang H; Zhang Q; Gao X; Liu F; Zhou S; Wang X; Niu Y; Hong Y; Lin SH; Liu WH; Xiao C; Li Q; Xiao N
Sci Adv; 2021 Dec; 7(49):eabk0490. PubMed ID: 34860557
[TBL] [Abstract][Full Text] [Related]
8. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
[TBL] [Abstract][Full Text] [Related]
9. mTOR Contributes to the Proteome Diversity through Transcriptome-Wide Alternative Splicing.
Cheng S; Fahmi NA; Park M; Sun J; Thao K; Yeh HS; Zhang W; Yong J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293270
[TBL] [Abstract][Full Text] [Related]
10. Complement C1q Binding Protein (C1QBP): Physiological Functions, Mutation-Associated Mitochondrial Cardiomyopathy and Current Disease Models.
Wang J; Huang CL; Zhang Y
Front Cardiovasc Med; 2022; 9():843853. PubMed ID: 35310974
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein: prospective biomarkers in digestive tract cancer.
Zhang Y; Zheng L
Transl Cancer Res; 2020 May; 9(5):3712-3720. PubMed ID: 35117733
[TBL] [Abstract][Full Text] [Related]
12. A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer.
Zhong X; Xuan F; Qian Y; Pan J; Wang S; Chen W; Lin T; Zhu H; Wang X; Wang G
BMC Cancer; 2021 Apr; 21(1):455. PubMed ID: 33892676
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
Trager MH; Rizk E; Rose S; Zhu K; Lau B; Fullerton BT; Pradhan J; Moore M; Srivastava AC; Singer G; Gartrell R; Chang R; Geskin LJ; Saenger YM; Goldenberg G
Sci Rep; 2021 Apr; 11(1):8775. PubMed ID: 33888854
[TBL] [Abstract][Full Text] [Related]
14. EZH2 knockdown in tamoxifen-resistant MCF-7 cells unravels novel targets for regaining sensitivity towards tamoxifen.
Kumari K; Kumar S; Parida DK; Mishra SK
Breast Cancer; 2021 Mar; 28(2):355-367. PubMed ID: 32990923
[TBL] [Abstract][Full Text] [Related]
15. p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis.
Noh S; Phorl S; Naskar R; Oeum K; Seo Y; Kim E; Kweon HS; Lee JY
Sci Rep; 2020 Jun; 10(1):10618. PubMed ID: 32606429
[TBL] [Abstract][Full Text] [Related]
16. Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.
Saha SK; Kim KE; Islam SMR; Cho SG; Gil M
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30991713
[TBL] [Abstract][Full Text] [Related]
17. Complement component 1q subcomponent binding protein in the brain of the rat.
Barna J; Dimén D; Puska G; Kovács D; Csikós V; Oláh S; Udvari EB; Pál G; Dobolyi Á
Sci Rep; 2019 Mar; 9(1):4597. PubMed ID: 30872665
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
